No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs150166449 |
chr6:150689305-150689306 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
2 |
rs562495982 |
chr6:150689433-150689434 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
3 |
rs145668170 |
chr6:150689469-150689470 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
4 |
rs561450386 |
chr6:150689487-150689488 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
5 |
rs545361932 |
chr6:150689493-150689494 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
6 |
rs565130749 |
chr6:150689546-150689547 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
7 |
rs368043865 |
chr6:150689571-150689572 |
Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
8 |
rs530591982 |
chr6:150689633-150689634 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs148925063 |
chr6:150689654-150689655 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs572258385 |
chr6:150689682-150689683 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs564159351 |
chr6:150689694-150689695 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs192001932 |
chr6:150689695-150689696 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs567440224 |
chr6:150689707-150689708 |
Enhancers Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs74801400 |
chr6:150689782-150689783 |
Enhancers Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs549456328 |
chr6:150689817-150689818 |
Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs568953347 |
chr6:150689834-150689835 |
Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs111510674 |
chr6:150689927-150689928 |
Flanking Active TSS Active TSS Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs143667751 |
chr6:150689968-150689969 |
Flanking Active TSS Active TSS Enhancers
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs558030060 |
chr6:150690008-150690009 |
Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs185774619 |
chr6:150690038-150690039 |
Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs534768108 |
chr6:150690040-150690041 |
Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs534417519 |
chr6:150690060-150690061 |
Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs377276436 |
chr6:150690074-150690075 |
Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs370916801 |
chr6:150690088-150690089 |
Enhancers Flanking Active TSS Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs375930689 |
chr6:150690126-150690127 |
Enhancers Flanking Active TSS Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs368894640 |
chr6:150690143-150690144 |
Enhancers Flanking Active TSS Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs374342127 |
chr6:150690147-150690148 |
Enhancers Flanking Active TSS Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs377735219 |
chr6:150690152-150690153 |
Enhancers Flanking Active TSS Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
29 |
rs370833097 |
chr6:150690156-150690157 |
Enhancers Flanking Active TSS Active TSS
|
TF binding regionCpG island
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
30 |
rs139564050 |
chr6:150690217-150690218 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
31 |
rs529565369 |
chr6:150690226-150690227 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
32 |
rs138283020 |
chr6:150690236-150690237 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
33 |
rs542404963 |
chr6:150690237-150690238 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
34 |
rs373765215 |
chr6:150690256-150690257 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
35 |
rs146748197 |
chr6:150690257-150690258 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
36 |
rs576111517 |
chr6:150690264-150690265 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
37 |
rs544994595 |
chr6:150690265-150690266 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
38 |
rs376472194 |
chr6:150690282-150690283 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
39 |
rs370872496 |
chr6:150690289-150690290 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
40 |
rs199986199 |
chr6:150690292-150690293 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
41 |
rs373631895 |
chr6:150690296-150690297 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
42 |
rs371640386 |
chr6:150690381-150690382 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
43 |
rs188651474 |
chr6:150690382-150690383 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
44 |
rs529891552 |
chr6:150690416-150690417 |
Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
45 |
rs142862233 |
chr6:150690432-150690433 |
Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
46 |
rs371194462 |
chr6:150690502-150690503 |
Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs568961574 |
chr6:150690503-150690504 |
Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs140885704 |
chr6:150690517-150690518 |
Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs59338764 |
chr6:150690600-150690601 |
Weak transcription Flanking Active TSS Active TSS Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs111677529 |
chr6:150690606-150690607 |
Weak transcription Flanking Active TSS Active TSS Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|